Zheng, Sunyi
Liu, Jiaxin
Xie, Jiping
Zhang, Wenjia
Bian, Keyi
Liang, Jing
Li, Jingxiong
Wang, Jing
Ye, Zhaoxiang
Yue, Dongsheng
Cui, Xiaonan
Funding for this research was provided by:
National Natural Science Foundation of China (82171932, 82171932, 82171932)
Article History
Received: 2 November 2024
Accepted: 17 March 2025
First Online: 28 March 2025
Declarations
:
: The study received approval from the medical ethical committee of the Tianjin Medical University Cancer Institute and Hospital (EK2023044).
: Not applicable.
: The authors declare no competing interests.
: IASLC International Association for the Study of Lung Cancer Pathology Committee.ADC invasive non-mucinous adenocarcinoma.PS predominant subtypes.HGP high-grade patterns.AUC Area Under the Curve.ICC Intraclass Correlation Coefficient.mRMR Minimum Redundancy Maximum Relevance.LASSO Least Absolute Shrinkage and Selection Operator.OR Odds Ratio.CI Confidence Interval.
: 1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Radiology, Tianjin, China. 2Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Department of Lung Cancer, Lung Cancer Center, Tianjin, China. 3The Second Hospital of Shanxi Medical University, Department of Radiology, Taiyuan, China. 4Zhejiang University, College of Computer Science and Technology, Hangzhou, China. 5Tianjin University of Traditional Chinese Medicine, School of Public Health, Tianjin, China.